Skip to search.
 TSX Up 0.13% TSX Ventures Down 0.17%

Celgene Corporation (CELG)

-NasdaqGS
120.71 Up 1.14(0.95%) Mar 5, 4:00PM EST
|Pre-Market : 120.98 7:49PM EST
Add to Portfolio
Prev Close:119.57
Open:120.48
Bid:115.00 x 1100
Ask:122.76 x 100
1y Target Est:137.83
Beta:1.77
Earnings Date:Apr 22 - Apr 27 (Est.)
Day's Range:119.76 - 121.76
52wk Range:66.85 - 125.45
Volume:3,583,196
Avg Vol (3m):5,687,090
Market Cap:96.64B
P/E (ttm):50.51
EPS (ttm):2.39
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
CELGUp 0.95%96.64B
JNJUp 0.86%285.06B

Key Statistics

Forward P/E (1 yr):19.13
P/S (ttm):12.48
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-15) :4.83
Quarterly EPS Est (Mar-15) :1.07
Mean Recommendation*:1.8
PEG Ratio (5 yr expected):0.98

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Celgene Corporation, a biopharmaceutical company, discovers, develops, and commercializes therapies to treat cancer and inflammatory diseases in the United States and Internationally. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback